Safety and Effectiveness of a 2009 H1N1 Vaccine in Beijing (NEJM, abstract, edited)
[Source: New England Journal of Medicine, full text: <cite cite="http://www.nejm.org/doi/full/10.1056/NEJMoa1006736?query=TOC"...
Announcement
Collapse
No announcement yet.
Search Result
Collapse
8 results in 0.0610 seconds.
Keywords
Members
Tags
-
Euro Surveill. Adverse drug effects following oseltamivir mass treatment and prophylaxis in a school outbreak of 2009 pandemic influenza A(H1N1) in June 2009, Sheffield, United Kingdom
Adverse drug effects following oseltamivir mass treatment and prophylaxis in a school outbreak of 2009 pandemic influenza A(H1N1) in June 2009, Sheffield, United Kingdom (Euro Surveill., abstract, edited)
[Source: EuroSurveillance.org,...
-
Archive: Hong Kong (PRC SAR): Epidemiological Surveillance, Pandemic Influenza H1N1 2009, from Centre of Health Protection (CHP) - Jan 3-Feb 28, 2010
Hong Kong: A fatal human swine influenza case at United Christian Hospital (1/3/10)
The following is issued on behalf of the Hospital Authority:
The spokesperson of United Christian Hospital (UCH) made the following announcement...
-
Giuseppe started a topic Vaccine development: experience from H5N1 to pandemic (H1N1) 2009 (WHO, presentation)in WHO (OMS)Vaccine development: experience from H5N1 to pandemic (H1N1) 2009 (WHO, presentation)
Source Full PDF Document: Marie-Paule Kieny - Vaccine development: experience from H5N1 to pandemic (H1N1) 2009 [pdf 1.26Mb]
-
Giuseppe started a topic Lancet. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.in VaccinesLancet. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.
Lancet. 2009 Oct 30. [Epub ahead of print]
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.
Black S, Eskola J, Siegrist CA, Halsey N, Macdonald...
-
Ann Intern Med. Safety and Efficacy of Extended-Duration Antiviral Chemoprophylaxis Against Pandemic and Seasonal Influenza.
Ann Intern Med. 2009 Aug 3. [Epub ahead of print]
Safety and Efficacy of Extended-Duration Antiviral Chemoprophylaxis Against Pandemic and Seasonal Influenza.
Khazeni N, Bravata DM, Holty JE, Uyeki TM, Stave CD, Gould MK....
-
Euro Surveill. Oseltamivir adherence and side effects among children in three London schools affected by influenza A(H1N1)v, May 2009 ? an internet-based cross-sectional survey
Eurosurveillance - Oseltamivir adherence and side effects among children in three London schools affected by influenza A(H1N1)v, May 2009 ? an internet-based cross-sectional survey
Eurosurveillance, Volume 14, Issue 30, 30 July 2009...
-
Giuseppe started a topic Vaccine. Adverse Events Rarely Reported after Trivalent Inactivated Influenza Vaccine (TIV) in Children 6-23 Months of Age.in VaccinesVaccine. Adverse Events Rarely Reported after Trivalent Inactivated Influenza Vaccine (TIV) in Children 6-23 Months of Age.
Vaccine. 2009 May 15. [Epub ahead of print]
Adverse Events Rarely Reported after Trivalent Inactivated Influenza Vaccine (TIV) in Children 6-23 Months of Age.
Rosenberg M, Sparks R, McMahon A, Iskander J, Campbell JD, Edwards...